Zheng; Bojian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zheng; Bojian.The latest application filed is for "compound that inhibits binding of influenza-virus pb subunit to rna cap".

Company Profile

2.10.7

Zheng; Bojian - Vancouver CA
Zheng; Bojian - Hong Kong CN
Zheng; Bojian - Hong Kong Sar CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibiting binding of influenza-virus PB2 subunit to RNA cap Grant 10,792,275 - Zheng , et al. October 6, 2	2020-10-06
Compound that Inhibits Binding of Influenza-Virus PB Subunit to RNA Cap App 20190142785 - ZHENG; Bojian ; et al.	2019-05-16
Method of preventively treating a subject at the risk of developing infections of a respiratory virus Grant 9,822,155 - Zheng , et al. November 21, 2	2017-11-21
Method Of Preventively Treating A Subject At The Risk Of Developing Infections Of A Respiratory Virus App 20160368956 - Zheng; Bojian ; et al.	2016-12-22
Peptides having activity of inhibiting infections of respiratory viruses and use of the same Grant 9,464,123 - Zheng , et al. October 11, 2	2016-10-11
Peptides Having Activity of Inhibiting Infections of Respiratory Viruses and Use of the Same App 20150152149 - Zheng; Bojian ; et al.	2015-06-04
SiRNA compositions and methods for potently inhibiting viral infection Grant 8,828,962 - Zheng , et al. September 9, 2	2014-09-09
Compositions for treating respiratory viral infections and their use Grant 8,691,781 - Tang , et al. April 8, 2	2014-04-08
siRNA compositions and methods for potently inhibiting viral infection Grant 8,664,188 - Zheng , et al. March 4, 2	2014-03-04
siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION App 20100166661 - ZHENG; BOJIAN ; et al.	2010-07-01
Combination Therapy For The Treatment Of Influenza App 20090298797 - Zheng; Bojian ; et al.	2009-12-03
Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof Grant 7,491,489 - Zheng , et al. February 17, 2	2009-02-17
Compositions For Treating Respiratory Viral Infections and Their Use App 20080279920 - Tang; Qingquan ; et al.	2008-11-13
Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof App 20060110758 - Zheng; Bojian ; et al.	2006-05-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.